NCT00072410View on ClinicalTrials.gov

Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

May 31, 2005

Study Completion Date

November 15, 2006

Conditions
Ovarian Cancer
Interventions
BIOLOGICAL

90Y-hu3S193

Patients received a single dose of 10 mg of hu3S193 radiolabeled with the intended dose (mCi) of 90Y.

BIOLOGICAL

111In-hu3S193

Patients received a single dose of 5 mCi 111In-hu3S193 together with the 90Y-hu3S193.

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Ludwig Institute for Cancer Research

OTHER